TRIM2 and neoplasm: Even when accounting for established prognostic factors such as tumour size, tumour grade, and lymph node stage, high TRIM2 mRNA expression remained a powerful predictor of BCSS (p < 0.01, Supplementary Table S2), reinforcing its potential as an independent prognostic marker.